Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial
Vedang Murthy(Homi Bhabha National Institute), Umesh Mahantshetty(Homi Bhabha National Institute), Palak Popat(Tata Memorial Hospital), Venkatesh Rangarajan(Tata Memorial Hospital), Gitanjali Panigrahi(Homi Bhabha National Institute), Smruti Mokal(Tata Memorial Hospital), Rahul Krishnatry, Dipika Chaurasiya(Homi Bhabha National Institute), Gagan Prakash(Homi Bhabha National Institute), Priyamvada Maitre(Homi Bhabha National Institute), Vanita Noronha, Ganesh Bakshi(P. D. Hinduja Hospital and Medical Research Centre), Santosh Menon(Homi Bhabha National Institute), Amit Joshi, Reena Phurailatpam(Tata Memorial Hospital), Kumar Prabhash(Homi Bhabha National Institute), Nilesh Sable(Homi Bhabha National Institute), Mahendra Pal(Homi Bhabha National Institute), Archi Agarwal(Homi Bhabha National Institute), Sadhana Kannan(Homi Bhabha National Institute)
Cited by 338
Related Papers
The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies
|Clinical and Translational Radiation Oncology|2018|932
Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study
|Radiotherapy and Oncology|2016|695
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694